SILVERARC CAPITAL MANAGEMENT, LLC – Seres Therapeutics, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$2.35M
portfolio value
SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+87.17%
quarter
Seres Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +5.39% | 18.73K shares | 1.16M | $6.42 | 366.49K |
Q2 2022 | share | Increase | +6.39% | 20.88K shares | -1.13M | $3.43 | 347.76K |
Q1 2022 | share | Increase | +1.96% | 6.27K shares | -344K | $7.12 | 326.87K |
Q4 2021 | share | Increase | +16.65% | 45.76K shares | 758K | $8.55 | 320.60K |
Q3 2021 | call | Decrease | -100.00% | -122.7K shares | -2.92M | $6.96 | 0 |
Q3 2021 | share | Increase | +330.00% | 210.91K shares | 389K | $6.96 | 274.83K |
Q2 2021 | call | Increase | 0.00% | 122.7K shares | 2.92M | $23.85 | 122.7K |
Q2 2021 | share | Decrease | -36.09% | -36.08K shares | -535K | $23.85 | 63.91K |
Q1 2021 | share | Increase | +300.00% | 75K shares | 1.44M | $20.59 | 100K |
Q4 2020 | share | Increase | 0.00% | 25K shares | 613K | $24.5 | 25K |